Publication | Open Access

5-Fluorouracil as protracted continuous intravenous infusion can be added to full-dose docetaxel (Taxotere®)–cisplatin in advanced gastric carcinoma: a phase I–II trial

Full-dose DocetaxelOncologyGastrointestinal OncologyMedicineAdvanced Gastric CarcinomaPharmacotherapyAnti-cancer AgentCancer TreatmentRadiation OncologyPharmacologyCancer ChemotherapyMolecular OncologyPhase I–ii Trial